Text and Data Mining valid from 2018-09-26
Received: 20 October 2017
Accepted: 14 September 2018
First Online: 26 September 2018
: All procedures were in accordance with the ethical standards of the FAU Erlangen-Nürnberg and the Helsinki Declaration. All analyses beyond diagnostic procedures were part of the study “Aufklärung genetischer Ursachen für familiären Brust- und Eierstockkrebs” approved by the ethics committee of the Friedrich-Alexander-Universität Erlangen-Nürnberg (Ethik-Kommission der FAU, No. 46_15 B). Written informed consent for diagnostic procedure (§3 Nr. 7 GenDG) in accordance with the Gendiagnostik-Kommission (GEKO, ExternalRef removed) of the Bundesministerium für Gesundheit of the German Government was obtained from all participants in this study.
: Not applicable.
: Peter A. Fasching received honoraria from Novartis, Pfizer, Roche and Celgene. Peter A. Fasching’s institution received research funding from Novartis. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.